Introduction
The treatment of slipped capital femoral epiphysis, or SCFE, usually involves stopping further slippage of the femoral head, stabilizing the growth plate, and correcting or reducing the mechanical stress that caused the displacement. The main approaches are surgical fixation, limited or complete reduction in selected cases, temporary activity restriction before treatment, and longer-term monitoring for hip function and complications. These treatments are designed to address the underlying biological problem: a weakened proximal femoral growth plate that allows the femoral head to shift relative to the femoral neck under normal loading forces.
SCFE occurs when the epiphysis, or femoral head, moves posteriorly and inferiorly through the growth plate. The condition is not primarily a cartilage disease of the joint surface but a failure of the physis, the zone of growing tissue between the femoral head and neck. Treatment focuses on mechanically stabilizing this unstable area, reducing the risk of worsening displacement, and preserving blood supply to the femoral head. When treated appropriately, the goal is to maintain joint congruence and reduce later deformity, pain, and early arthritis.
Understanding the Treatment Goals
The main goal in SCFE treatment is to prevent additional displacement of the femoral head across the growth plate. Continued slippage changes the shape and alignment of the proximal femur, which alters hip mechanics and increases impingement between the femoral neck and the acetabulum. Because the abnormal movement occurs through the physis, treatment is aimed at eliminating shear forces across this weak region.
Another goal is to reduce symptoms such as pain, limp, and limited hip motion. These symptoms arise from both the mechanical instability at the physis and the altered geometry of the hip after slippage. Stabilization can decrease pain by preventing ongoing micro-movement and reducing irritation of the surrounding soft tissues.
A further goal is to reduce long-term complications. SCFE can lead to femoroacetabular impingement, chondrolysis, avascular necrosis, leg-length discrepancy, and premature osteoarthritis. Treatment decisions are shaped by the need to preserve femoral head blood supply, maintain joint motion, and limit deformity that would otherwise alter hip loading for years after the growth plate closes.
The severity and stability of the slip determine how aggressively the condition is treated. Stable slips tend to be managed differently from unstable slips because unstable lesions carry a greater risk of vascular compromise and structural failure. The treatment plan is therefore based not only on symptom relief, but on the mechanical and vascular biology of the growing hip.
Common Medical Treatments
There is no medication that corrects the slipped epiphysis itself. Medical treatment is mainly supportive and temporary, used to reduce stress on the hip before definitive intervention. The most common immediate measure is activity restriction and non-weight-bearing or protected weight-bearing. This reduces shear forces across the open growth plate, limiting further displacement while the patient is awaiting stabilization. By decreasing load transmission through the unstable physis, this approach addresses the mechanical trigger that worsens the deformity.
Pain control is another component of medical management. Analgesic medications can reduce discomfort caused by inflammation, soft tissue strain, and altered joint mechanics. They do not repair the slip, but they decrease nociceptive signaling while the underlying structural problem is being corrected. In practical terms, pain management supports stabilization and reduces involuntary loading caused by painful movement patterns.
In endocrine or metabolic-associated SCFE, treatment may also include management of the underlying disorder. Conditions such as hypothyroidism, growth hormone abnormalities, renal osteodystrophy, or hypogonadism can weaken the growth plate or alter physeal maturation. Treating these conditions can improve the biological environment of the skeleton, reduce ongoing vulnerability of the growth plate, and lower the likelihood of bilateral involvement or recurrence in the remaining open physis.
For many patients, medical treatment alone is not definitive because the slipped epiphysis remains mechanically unstable. However, these measures are biologically relevant because they reduce load, limit progression, and address systemic factors that contribute to physeal weakness.
Procedures or Interventions
The standard treatment for most cases of SCFE is surgical stabilization with in situ fixation. This procedure involves placing a screw or similar device across the growth plate to hold the epiphysis in position relative to the femoral neck. The aim is not to restore a normal shape immediately, but to stop further slippage by converting an unstable physis into a mechanically stable construct. By fixing the epiphysis in place, the surgery interrupts the shear motion that otherwise continues to deform the proximal femur.
In situ fixation works through purely mechanical principles. The implant resists translational force across the weakened physis, allowing the bone to heal and the growth plate to eventually close in a stable position. This is particularly important in stable slips, where the blood supply to the femoral head is usually intact and the main threat is progression of deformity rather than immediate loss of viability.
In unstable SCFE, treatment may be more urgent because the blood supply to the femoral head is at greater risk. Surgical stabilization is still the core approach, but careful handling is required to avoid further vascular injury. Unstable slips may sometimes be managed with a very gentle or limited reduction before fixation, depending on the surgeon’s assessment of the risks. The biological issue here is that the retinacular vessels supplying the femoral head can be stretched or disrupted by displacement and by aggressive manipulation. Avoiding additional trauma helps preserve perfusion and reduce the chance of avascular necrosis.
Reduction procedures are reserved for selected cases. Mild reduction may improve alignment and reduce future impingement, but complete forceful reduction is generally avoided because sudden correction can compromise the femoral head blood supply. The tradeoff reflects the anatomy of SCFE: the deformity is partly mechanical, but the head still depends on delicate vascular structures that can be injured by large corrective forces.
For severe chronic deformities, later reconstructive procedures may be required if the original slip leaves a persistent cam-type deformity or significant motion loss. These interventions may include surgical reshaping of the femoral head-neck junction or corrective osteotomy. Such procedures alter the bone geometry to reduce impingement and restore more normal hip mechanics. They do not treat the original physeal failure, but they address the structural consequences of the slip once the growth plate has closed or the deformity has become established.
If both hips are at risk, prophylactic fixation of the opposite hip may be considered in some cases. This is not treatment of a slipped hip itself, but a preventive intervention aimed at the contralateral growth plate when its biological or mechanical risk is high. The rationale is that the underlying predisposition can affect both sides, especially in younger patients or those with endocrine disease.
Supportive or Long-Term Management Approaches
Long-term management focuses on monitoring healing, hip development, and the appearance of complications after fixation. Follow-up imaging is used to confirm that the slip has not progressed and that the implant remains stable. Radiographic surveillance also helps assess whether the femoral neck retains an abnormal shape that may later cause impingement.
Rehabilitation may be used to restore range of motion and gait mechanics after the hip has stabilized. Because SCFE often leads to external rotation deformity and reduced internal rotation, the surrounding muscles and movement patterns can adapt to the altered shape of the proximal femur. Gradual rehabilitation works by improving mobility and function around a healed but still structurally altered joint.
Long-term observation is especially important because the effects of SCFE often emerge after the acute phase has passed. Even when the slip is stabilized, the changed contour of the femoral head-neck junction may lead to abnormal contact during hip motion. This can damage the labrum and articular cartilage over time. Monitoring allows clinicians to detect persistent impingement, stiffness, or degenerative change while symptoms are still limited.
In patients with endocrine or metabolic contributors, ongoing treatment of the underlying disorder is part of long-term management. This helps reduce stress on the growth plate in the remaining immature skeleton and can improve overall bone health. Because SCFE is often a manifestation of a broader physiologic problem, treating the systemic condition influences the risk of additional orthopedic complications.
Factors That Influence Treatment Choices
Treatment varies according to whether the slip is stable or unstable. Stable slips allow the patient to bear weight, though usually with pain, and are generally treated with prompt fixation. Unstable slips, where the patient cannot walk, have a higher risk of vascular injury and tend to be managed with greater urgency and caution. This distinction matters because the mechanical state of the slip affects the likelihood of femoral head survival.
The degree of displacement also influences treatment. Mild slips are usually stabilized in situ, while more severe deformities may later require corrective procedures if they cause significant impingement or loss of motion. Greater displacement changes the lever arm and shape of the proximal femur, increasing the mechanical consequences even after fixation.
Age and skeletal maturity are important because the growth plate’s remaining activity determines both the risk of further slip and the potential for remodeling. Younger patients with substantial growth remaining may be more vulnerable to progression or contralateral disease. In older adolescents, the physis is closer to closure, which changes both the biology of the lesion and the potential benefit of preventive fixation.
Associated conditions also affect treatment selection. Endocrine, renal, and metabolic disorders may make SCFE more likely, more severe, or more bilateral. In these cases, treatment decisions often incorporate management of the systemic disorder because the underlying bone biology remains abnormal even after the hip is stabilized.
Previous treatment response matters as well. If fixation fails, if deformity progresses, or if impingement symptoms persist after healing, additional surgery may be needed. The choice of intervention depends on whether the main problem is instability, residual deformity, vascular compromise, or later joint degeneration.
Potential Risks or Limitations of Treatment
Surgical fixation carries the risk of injury to the femoral head blood supply, especially in unstable slips or when reduction is attempted. The proximal femur depends on a limited vascular network, and disruption of that network can cause avascular necrosis, a serious complication in which the femoral head loses its blood supply and collapses. This risk arises from the anatomy of the hip and the proximity of the surgical intervention to the retinacular vessels.
Another limitation is that fixation stops progression but does not necessarily restore normal anatomy. Even after successful stabilization, the femoral head-neck offset may remain abnormal. This residual deformity can produce femoroacetabular impingement during flexion and rotation, which may eventually damage cartilage and the labrum. Thus, treatment can preserve the joint but still leave a structural predisposition to later symptoms.
Hardware-related complications can also occur. Screws may be placed too deeply, too shallowly, or in a position that fails to fully control the slip. In a growing child, implants must be positioned carefully to secure the epiphysis while minimizing damage to the physis and surrounding structures. Because the biological target is a living growth plate, precision matters more than in fixation of mature bone.
Growth-related complications are another concern. If the physis closes asymmetrically or the deformity alters limb alignment, leg-length discrepancy or altered hip mechanics can result. These outcomes reflect the fact that SCFE occurs during skeletal growth, so treatment must balance stability against the changing anatomy of a developing skeleton.
Nonoperative measures are limited because they do not correct the mechanical instability. Activity restriction and pain management may reduce further stress temporarily, but they cannot restore the structural integrity of the growth plate. Their limitation is biological: the underlying physeal failure persists until it is stabilized by fixation or until skeletal maturity ends the risk of slip.
Conclusion
SCFE is treated primarily by stabilizing the slipped epiphysis and preventing further displacement through the weak growth plate. The core treatment is usually surgical fixation, often with in situ screw placement, because this directly counteracts the shear forces that drive the condition. Supportive measures such as limiting weight-bearing and controlling pain are used to reduce stress before definitive treatment, while endocrine or metabolic disorders are managed when they contribute to physeal weakness.
Long-term care focuses on preserving hip function, monitoring for vascular complications, and recognizing residual deformity that may cause impingement or arthritis later in life. Treatment choices depend on slip stability, severity, skeletal maturity, and associated medical conditions. Across all approaches, the central principle is the same: management works by addressing the mechanical instability and physiologic vulnerability of the proximal femoral growth plate, rather than simply treating symptoms alone.